Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hybrid vs Reverse Hybrid vs Levofloxacin Quadruple for H. Pylori
NCT04039412Phase 4Completed
- Start
- Jun 2018
- Primary completion
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of omeprazole, amoxicillin, clarithromycin, metronidazole, levofloxacin in Helicobacter pylori infection. Started Jun 2018; status: completed.
02
Drugs
omeprazoleamoxicillinclarithromycinmetronidazolelevofloxacin
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT04039412.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04039412.